Medical Meetings

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Dec
04
ASH 2016: Amyloidosis Overview
An overview of Amyloidosis updates and abstracts at ASH 2016. Dr. Gertz talks about the new drugs NEOD001and 11-1F4; use of daratumumab and carfilzomib in patients with cardiac amyloid.
Dec
04
ASH 2016: Multiple Myeloma Overview - Dr. Morie Gertz
An overview of multiple myeloma presentations at ASH 2016 by Dr. Morie Gertz of the Mayo Clinic, Rochester, MN.
Dec
04
ASH 2016: Findings of Whole Body Computed Tomography Compared to CSS in Patients with MPCD
For decades conventional skeletal survey (CSS) has been the standard imaging technique for the detection of bone impairment caused by Multiple Myeloma (MM). The development of cross-sectional imaging(...)
Dec
03
ASH 2016: Multiplem Myelom Überblick
An overview of multiple myeloma presentations at ASH 2016 by Dr. Jens Hillengass of the University Hospital Heidelberg, Heidelberg, Germany.
Dec
03
ASH 2016: Panoramica Multiplo Mieloma
An overview of multiple myeloma presentations at ASH 2016 by Dr. Elena Zamagni of the Bologna University School of Medicine Bologna, Italy. .
Dec
03
ASH 2016: Longitudinal FiSH at Primary Diagnosis and Relapse Reveals Clonal Evolution after ASCT in MM
Multiple myeloma is a heterogeneous disease with survival ranging from months to more than 10 years. Cytogenetic abnormalities (CA) detected by fluorescence in situ hybridization (FISH) are of major(...)